Skip to content

Traditional Chinese medicine syndromes and risk factors of fatty liver in Yunnan were studied based on gene polymorphism

Traditional Chinese medicine syndromes and risk factors of fatty liver in Yunnan were studied based on gene polymorphism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098456
Enrollment
Unknown
Registered
2025-03-07
Start date
2024-06-25
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic fatty liver disease

Interventions

Fatty liver patients group:N/A
Non-fatty liver disease group:N/A

Sponsors

Yunnan Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Between the ages of 18 and 65, male or female; (2) Ultrasonic /CT diagnosis and instantaneous elastic imaging were consistent with the diagnosis of fatty liver; (Ultrasound /CT prior to 6 months A fatty liver diagnosis may also be included); (3) In line with the dialectical standard of traditional Chinese medicine for non-alcoholic fatty liver disease; (4) Informed consent, voluntary participation in the investigation, willing to cooperate with the investigation and complete the relevant main observation indicators.

Exclusion criteria

Exclusion criteria: (1) Concurrent viral hepatitis (hepatitis B, hepatitis C), genotype 3 hepatitis C, drug-induced liver injury, self Immune liver disease, total gastrointestinal nutrition, celiac disease, hypothyroidism, hypercortisol syndrome, inflammatory bowel disease, beta-fatty eggs Patients with specific diseases such as leukaemia, hepatolenticular degeneration, and long-term use of glucocorticoids that can lead to fatty liver; (2) Long-term excessive alcohol intake (male equivalent ethanol amount < 30g/d, female < 20g/d); (3) Patients with digestive tract malignant tumor; (4) Pregnant and lactating women, who are preparing to become pregnant recently; (5) Failure to complete the main outcome indicators (such as: liver and kidney function, blood lipid, blood glucose, blood routine, hemorheology, hepatitis markers Objects and other laboratory tests) patients.

Design outcomes

Primary

MeasureTime frame
Abdomen ultrasound;Bood biochemistry;Blood routine examination;Hepatitis virus detection;

Countries

China

Contacts

Public ContactChen Wenhui

Yunnan Provincial Hospital of Traditional Chinese Medicine

cwh6581908@126.com+86 137 0069 0775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026